About
Non-invasive, home-administered wearable ultrasound devices
Areas of Focus
Categories
Medical MeasurementBoston & New England
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
818
By Phase
PHASE3: 2PHASE2: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 4TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02547623Lead Sponsor
Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery
PHASE3Completed
194 participants
Started: Nov 6, 2015 · Completed: Aug 16, 2016
NCT02006888Lead Sponsor
The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery
PHASE3Completed
394 participants
Started: Jan 31, 2014 · Completed: Oct 31, 2014
NCT01606735Lead Sponsor
Efficacy and Safety of IBI-10090 in Ocular Surgery Patients
PHASE2Completed
172 participants
Started: Apr 30, 2012 · Completed: Mar 31, 2013
NCT01214174Lead Sponsor
Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients
PHASE2Terminated
42 participants
Started: Oct 31, 2010 · Completed: May 31, 2012
NCT01175395Collaborator
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
PHASE1/PHASE2Completed
10 participants
Started: Sep 30, 2010 · Completed: Jan 31, 2013
Funding History (1)
D
Sep 25, 2024
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...